study or research results that show the possibility of providing innovative financial services; (6) having no record of violating or failing to comply with the regulations or conditions related to
from the approval date; (5) having the study or research results that show the possibility of providing innovative financial services; (6) having no record of violating or failing to comply with the
/2563 2.1543 3.4271 5.5814 246003662005-1 HUMAN WASATCH ADVISORS, INC. จำหน่าย หุ้น 5.8926 0.9036 4.989 13/02/2563 5.8926 0.9036 4.989 246002552002-1 HUMAN CAPITAL RESEARCH AND MANAGEMENT COMPANY
professionals, especially securities analysts, to attain better knowledge and deeper learning of ESG data analysis and integrate this information into their research reports. In addition, the emphasis on ESG in
-border publication of research reports to facilitate better information flow of ASEAN capital market products as part of its ongoing efforts to promote professional mobility and wider investor
Laboratory and Research Center (“AMARC”). Costs and Expenses The Company reported the consolidated costs and expenses for Q1/2019 of Baht 345.54 million, nearby of Q1/2018 of Baht 345.61 million decreased by
booked in year 2018 for chronic diseases were then subtracted accordingly. However, the service revenues (mainly received from Asia Medical and Agricultural Laboratory and Research Center Co., Ltd “AMARC